TP53 mutation variant allele frequency is a potential...

Oncotarget 2016 / 06 Vol. 7; Iss. 24

TP53 mutation variant allele frequency is a potential predictor for clinical outcome of patients with lower-risk myelodysplastic syndromes

Belickova, Monika, Vesela, Jitka, Jonasova, Anna, Pejsova, Barbora, Votavova, Hana, Merkerova, Michaela Dostalova, Zemanova, Zuzana, Brezinova, Jana, Mikulenkova, Dana, Lauermannova, Marie, Valka, Jan
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
7
Journal:
Oncotarget
DOI:
10.18632/oncotarget.9200
Date:
June, 2016
File:
PDF, 5.59 MB
2016
Conversion to is in progress
Conversion to is failed